SMTI
Sanara Medtech Inc
35.20$
+0.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 80.8% | 83.2% | 91.9% | 91.9% | 32.2% | 79.7% | 45.6% | 67.6% | 33.8% | 25.7% | 37.8% | 46.0% | |
| 34.9% | 13.1% | 38.4% | 20.9% | 24.1% | 59.5% | 4.6% | 51.2% | 14.7% | 7.0% | 18.0% | 22.7% | |
| 34.9% | 13.1% | 38.4% | 20.9% | 24.1% | 59.5% | 4.6% | 51.2% | 14.7% | 7.0% | 18.0% | 22.7% | |
| 18.6% | 32.5% | 36.6% | 37.7% | 7.1% | 12.0% | 23.1% | 8.2% | 11.5% | 11.6% | 15.4% | 16.4% | |
| 26.9% | 29.4% | 16.0% | 32.1% | 15.3% | 6.7% | 11.7% | 5.6% | 5.8% | 6.4% | 3.1% | 5.4% | |
| – | 3.0% | 1.6% | 2.9% | 0.6% | 7.1% | 11.7% | 5.6% | 2.3% | – | – | – | |
| – | – | – | – | – | – | – | 0.0% | 5.9% | 4.9% | 4.1% | 4.9% | |
| 16.2% | 13.7% | 6.5% | 5.3% | 1.7% | 13.2% | 31.5% | 13.0% | 51.6% | 60.8% | 46.5% | 25.6% | |
| 155.1% | 191.3% | 119.5% | 95.4% | 63.4% | 42.5% | 40.6% | 17.2% | 31.6% | 39.6% | 55.8% | 91.9% | |
| 154.5% | 104.8% | 64.2% | 95.4% | 13.3% | 23.7% | 36.0% | 16.5% | 21.0% | 18.6% | 17.4% | 25.5% | |
| 106.6% | 44.5% | 19.4% | 54.1% | 0.3% | 1.1% | 1.3% | 0.6% | 0.5% | 1.3% | 0.4% | 0.5% | |
| 14.0% | 16.0% | 11.0% | 10.2% | 1.8% | 3.7% | 5.0% | 1.6% | 2.3% | 2.7% | 1.7% | 3.2% | |
| – | 86.2% | 55.3% | – | 49.3% | 13.5% | – | – | – | 12.3% | 34.8% | 63.0% | |
| -55.1% | -91.3% | -19.5% | 4.6% | 36.6% | 59.5% | 62.6% | 84.2% | 68.5% | 60.7% | 44.7% | 8.1% | |
| -3,032.9% | -3,361.4% | -2,173.8% | -2,113.2% | -1,560.4% | -24.1% | -71.6% | -41.9% | -38.3% | -38.0% | -42.9% | -103.2% | |
| 70.4% | 77.1% | 50.5% | 94.1% | 71.4% | 19.2% | 58.4% | 20.2% | 13.0% | 11.2% | 9.6% | 11.8% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.